We Are a Proud Sponsor of 2018 Life Sciences Dealmaking Symposium

We are pleased to announce that David Uffer, Senior Partner at Alira Health, was selected as a speaker for the Early-stage Investment Panel at the 2018 Life Sciences Dealmaking Symposium. Join us for a discussion on the current VC investment climate and what entrepreneurs and startups need to know to make their innovations marketable to investors.

Alira Health Chief Scientific Officer Mitch Sanders, Ph.D., Senior Partner Alan Lucas, and Manager Aude Ouensanga will also be in attendance and available throughout the conference to discuss how our advisory support can help to uncover opportunity and accelerate your innovations.

Please contact david.uffer@alirahealth.com to schedule your meeting or request more information.

We look forward to seeing you in Cambridge.


This year, it is McDermott Will & Emery’s 7th Annual Life Sciences Dealmaking Symposium. The Symposium will focus on the opportunities and challenges for those investing and operating in the global life sciences industry. Featuring panels of seasoned dealmakers, industry executives and technical experts who will provide practical guidance on how to navigate the ever-changing life sciences deal landscape, the Symposium will cover today’s hottest growth sectors. The Symposium, now a “must attend” event for life sciences dealmakers, gives attendees the opportunity to: learn how to best navigate the vibrant and complex life sciences deal landscape; hear best practices and success stories from experienced dealmakers; connect with other life sciences executives.


To receive new information, thought-provoking whitepapers, and opportunities to connect with healthcare experts on everything from regulatory and clinical trial challenges to strategy and financing solutions, we invite you to join our email list.